Fund Holdings — Redmile Group, LLC

Total Portfolio Value:
$1.70B
Total Bought:
$48.79M
Total Sold:
$213.49M
Net Transaction:
-$164.70M
Notable People:
Jeremy Charles Green, Joshua Damian Garcia, Bryan Ranney Crapo, Michael Stewart Lee, Robert Carrington Faulkner, Travis John Breznak
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Krystal Biotech, Inc.(KRYS)1,021,078810,245-210,833$187.51M$147.49M8.69%-$40.02M
Nurix Therapeutics, Inc.(NRIX)4,423,6164,280,981-142,635$92.32M$96.19M5.67%+$3.87M
Amicus Therapeutics Inc
COM
10,595,0898,246,592-2,348,497$105.10M$88.07M5.19%-$17.03M
Immunome, Inc.(IMNM)4,889,5544,889,5540$59.16M$71.49M4.21%+$12.32M
Kymera Therapeutics, Inc.(KYMR)1,579,2751,393,256-186,019$47.14M$65.94M3.88%+$18.80M
Zymeworks Inc.(ZYME)5,211,0375,101,911-109,126$44.35M$64.03M3.77%+$19.68M
Stoke Therapeutics, Inc.(STOK)4,721,0544,713,509-7,545$63.78M$57.93M3.41%-$5.85M
Replimune Group, Inc.(REPL)5,562,0964,781,183-780,913$50.06M$52.40M3.09%+$2.34M
Biohaven Ltd.(BHVN)1,087,5761,034,219-53,357$37.75M$51.68M3.04%+$13.93M
REGENXBIO Inc.(RGNX)4,569,8024,892,902+323,100$53.47M$51.33M3.02%-$2.14M
Igm Biosciences Inc3,072,4783,072,4780$21.11M$50.82M2.99%+$29.71M
ADC Therapeutics SASHS(ADCT)15,269,21715,669,217+400,000$48.25M$49.36M2.91%+$1.11M
Cogent Biosciences, Inc.(COGT)4,799,9734,484,380-315,593$40.46M$48.43M2.85%+$7.97M
Fate Therapeutics, Inc.(FATE)13,169,05713,169,0570$43.19M$46.09M2.72%+$2.90M
LivaNova PLCSHS(LIVN)929,506875,039-54,467$50.96M$45.97M2.71%-$4.98M
Scholar Rock Holding Corporation(SRRK)5,453,0835,238,837-214,246$45.42M$41.96M2.47%-$3.46M
Neurogene Inc.(NGNE)1,013,663964,347-49,316$36.89M$40.46M2.38%+$3.58M
Akero Therapeutics Inc1,614,4731,387,479-226,994$37.88M$39.81M2.35%+$1.93M
Beam Therapeutics Inc.(BEAM)1,703,0611,611,013-92,048$39.90M$39.47M2.33%-$432.9K
Augmedix Inc16,380,32716,380,3270$14.41M$38.49M2.27%+$24.08M
Annexon, Inc.(ANNX)6,427,4626,427,4620$31.49M$38.05M2.24%+$6.56M
Catalent Inc595,570595,5700$33.49M$36.07M2.13%+$2.58M
Pliant Therapeutics, Inc.(PLRX)3,209,5913,197,491-12,100$34.50M$35.84M2.11%+$1.34M
Silence Therapeutics plcADS(SLN)2,014,2961,899,317-114,979$38.27M$34.53M2.03%-$3.74M
Keros Therapeutics, Inc.(KROS)552,506552,5060$25.25M$32.08M1.89%+$6.83M
Absci Corporation8,253,3168,253,3160$25.42M$31.53M1.86%+$6.11M
Boston Scientific Corporation(BSX)390,253330,873-59,380$30.05M$27.73M1.63%-$2.33M
Celldex Therapeutics, Inc.(CLDX)718,723657,175-61,548$26.60M$22.34M1.32%-$4.26M
IDEAYA Biosciences, Inc.(IDYA)759,516681,150-78,366$26.67M$21.58M1.27%-$5.09M
Shattuck Labs, Inc.(STTK)5,615,4895,615,4890$21.68M$19.60M1.15%-$2.08M
BioNTech SEADS(BNTX)0154,456+154,456$0$18.34M1.08%+$18.34M
Immunovant, Inc.(IMVT)720,177642,229-77,948$19.01M$18.31M1.08%-$702.7K
4d Molecular Therapeutics In1,073,4351,262,090+188,655$22.53M$13.64M0.80%-$8.89M
Intuitive Surgical, Inc.(ISRG)39,84326,698-13,145$17.72M$13.12M0.77%-$4.61M
Stryker Corporation(SYK)39,48332,741-6,742$13.43M$11.83M0.70%-$1.61M
89bio Inc1,745,6561,569,850-175,806$13.98M$11.62M0.68%-$2.37M
Ardelyx Inc1,881,5011,660,763-220,738$13.94M$11.44M0.67%-$2.50M
Establishment Labs Holdings Inc.(ESTA)213,024261,803+48,779$9.68M$11.33M0.67%+$1.65M
Oruka Therapeutics, Inc.(ORKA)0411,728+411,728$0$10.09M0.59%+$10.09M
Prime Medicine, Inc.(PRME)2,074,3502,074,3500$10.66M$8.03M0.47%-$2.63M
ALX Oncology Holdings Inc.(ALXO)4,036,4513,836,576-199,875$24.34M$6.98M0.41%-$17.36M
Nuvation Bio Inc.CL A(NUVB)3,031,0093,031,0090$8.85M$6.94M0.41%-$1.91M
Verve Therapeutics Inc1,463,4061,383,366-80,040$7.14M$6.70M0.39%-$445.9K
Repare Therapeutics Inc1,942,5551,942,5550$6.41M$6.68M0.39%+$272.0K
AC Immune SASHS(ACIU)1,807,7041,694,167-113,537$7.21M$6.40M0.38%-$808.8K
Cytokinetics, Incorporated(CYTK)111,86797,116-14,751$6.06M$5.13M0.30%-$933.2K
Ventyx Biosciences Inc2,164,1262,107,215-56,911$5.00M$4.59M0.27%-$405.4K
Stereotaxis, Inc.(STXS)2,108,2192,108,2190$3.84M$4.30M0.25%+$463.8K
Atara Biotherapeutics Inc452,270452,2700$3.84M$3.68M0.22%-$167.3K
Boundless Bio, Inc.(BOLD)1,034,5831,023,548-11,035$4.00M$3.55M0.21%-$452.1K
Lava Therapeutics NvSHS2,074,3722,074,3720$3.73M$3.44M0.20%-$290.4K
Astria Therapeutics Inc0310,884+310,884$0$3.42M0.20%+$3.42M
Invivyd, Inc.(IVVD)3,065,7143,065,7140$3.37M$3.13M0.18%-$245.3K
Xeris Biopharma Holdings Inc1,046,5871,046,5870$2.35M$2.98M0.18%+$628.0K
Gritstone Bio Inc5,107,7324,920,178-187,554$3.16M$2.85M0.17%-$302.9K
Penumbra, Inc.(PEN)013,847+13,847$0$2.69M0.16%+$2.69M
Cabaletta Bio, Inc.(CABA)442,826442,8260$3.31M$2.09M0.12%-$1.22M
Allakos Inc3,077,8283,077,8280$3.08M$2.01M0.12%-$1.07M
Achilles Therapeutics PlcADS1,608,0891,608,0890$1.31M$1.64M0.10%+$329.7K
Allovir Inc1,907,9691,907,9690$1.38M$1.54M0.09%+$162.6K
Rapt Therapeutics Inc536,682504,532-32,150$1.64M$1.01M0.06%-$622.8K
Adaptimmune Therapeutics plcADR(ADAPY)715,607715,6070$697.6K$680.1K0.04%-$17.5K
Hookipa Pharma Inc0106,376+106,376$0$457.4K0.03%+$457.4K
Alpha Teknova, Inc.(TKNO)154,5090-154,509$211.7K$0—-$211.7K
Blueprint Medicines Corp94,4050-94,405$10.17M$0—-$10.17M
Entrada Therapeutics, Inc.(TRDA)560,9710-560,971$7.99M$0—-$7.99M
Hookipa Pharma Inc1,063,7690-1,063,769$629.5K$0—-$629.5K
Standard BioTools Inc.(LAB)411,6310-411,631$728.6K$0—-$728.6K
Page 1 of 1
Redmile Group, LLC — 13F Holdings — Q3 2024 | TickerTrail